Cochlear: a hedging strategy that shields $55 million a year
For one corporate treasurer, working out an effective hedging strategy was a matter of getting to the bottom of the board’s risk appetite.
With a market capitalisation of A$10.5 billion ($8.1 billion) Cochlear – the Sydney-based hearing implant business – is at the strong end of Australia’s mid-cap market.
Sign in to read on!
Registered users get 2 free articles in 30 days.
Subscribers have full unlimited access to CorporateTreasurer.
Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
If you are a treasurer, CFO or senior professional at a corporate or SME, please register for free VIP access here.
Questions?
See here for more information on licences and prices, or contact [email protected].
© Haymarket Media Limited. All rights reserved.
Top news, insights and analysis every Tuesday & Thursday
Free registration gives you access to our email newsletters
for unlimited access to all articles, newsletters
